1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Ustekinumab for the Prevention of Acute Graft-versus-Host Disease After Unrelated Donor Hematopoietic Cell TransplantHemic and Lymphatic Diseases, hematologic disorder, hematopoietic and lymphoid system neoplasmActive, not recruitingPhase 22026-01-02NCT04572815